Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06604039 · ClinicalTrials.gov registry record
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
A clinical trial of Vascular Access Device, sponsored by Teleflex.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 3
- Study locations
NCT06604039: Recruiting study of Vascular Access Device, sponsored by Teleflex.
NCT06604039 is a study of Vascular Access Device that is actively recruiting participants, run by Teleflex. The registered enrollment target is 2,500 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06604039, a study of Vascular Access Device, is actively recruiting participants, sponsored by Teleflex.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 3
- Study locations
Study Summary
The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
Primary Outcome
The proportion of device uses successfully completed without device removal due to device-related adverse events
Conditions Studied
Interventions
- DEVICE Central venous catheter
Study Locations (3)
Alabama
- Huntsville Hospital - Huntsville
California
- Loma Linda University Health - Loma Linda
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2024-12-08 |
| Est. Completion | 2034-12-07 |
What NCT06604039 shows while recruiting
NCT06604039 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Vascular Access Device appearing as the primary indexed condition, and to 1 intervention - of which Central venous catheter is the first listed.
NCT06604039 reports a single indexed study location in Alabama, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06604039 about?
NCT06604039 is a clinical study titled "A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices". The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
What is the current status of trial NCT06604039?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2024-12-08. Estimated completion is 2034-12-07.
What conditions does trial NCT06604039 study?
This clinical trial studies the following conditions: Vascular Access Device.
What interventions are being tested in trial NCT06604039?
The interventions under investigation include: Central venous catheter (DEVICE).
Who is sponsoring clinical trial NCT06604039?
This trial is sponsored by Teleflex, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06604039 being conducted?
This trial has 3 study locations across Alabama, California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI